KR20180050028A - Facial mask - Google Patents

Facial mask Download PDF

Info

Publication number
KR20180050028A
KR20180050028A KR1020160146680A KR20160146680A KR20180050028A KR 20180050028 A KR20180050028 A KR 20180050028A KR 1020160146680 A KR1020160146680 A KR 1020160146680A KR 20160146680 A KR20160146680 A KR 20160146680A KR 20180050028 A KR20180050028 A KR 20180050028A
Authority
KR
South Korea
Prior art keywords
weight
parts
ginseng
zinc oxide
skin
Prior art date
Application number
KR1020160146680A
Other languages
Korean (ko)
Inventor
쉬에허 후앙
Original Assignee
쉬에허 후앙
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 쉬에허 후앙 filed Critical 쉬에허 후앙
Priority to KR1020160146680A priority Critical patent/KR20180050028A/en
Publication of KR20180050028A publication Critical patent/KR20180050028A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212Face masks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A face mask and a method for manufacturing the same are provided. Wherein the face mask comprises 10 to 20 parts by weight of ginseng, 10 to 20 parts by weight of pearl powder, 10 to 20 parts by weight of peanuts, 10 to 20 parts by weight of vinegar, 10 to 20 parts by weight of extracts, 20 to 30 parts by weight of the extract, 20 to 30 parts by weight of phosphorus, 10 to 15 parts by weight of French chalk, 5 to 10 parts by weight of zinc oxide, and 5 to 10 parts by weight of Bolus alba. The advantageous effect of the present invention is that the raw materials of traditional Chinese medicines can interact with each other, act as a synergistic effect, promote blood circulation in the face, and absorb waste and toxic gases.

Description

Facial mask {FACIAL MASK}

The present invention relates to the field of skin care, and more particularly to the field of facial masks.

The face is more easily exposed to the surrounding environment as compared to other parts of the body and is therefore more often suffered from the effects of wind, sunburn, electromagnetic radiation, dust and the like. Due to the diverse skin characteristics of each person, some facial problems may arise, and those who perceive may be embarrassed or uncomfortable. More seriously, these problems can have a negative impact on people's occupations, marriage, and so on.

Facial masks are very popular for alleviating or eliminating facial problems. However, most face masks contain heavy metal or phosphor powder components, which can damage human skin when used for long periods.

Thus, there is a need for the development of facial masks with natural and safe ingredients that are suitable for long-term use and which reduce cuts on the skin.

It is an object of the present invention to provide a safe and effective face mask for facial care.

According to one aspect of the present invention there is provided a pharmaceutical composition comprising 10 to 20 parts by weight of ginseng, 10 to 20 parts by weight of pearl powder, 10 to 20 parts by weight of Angelica dahurica, 10 to 20 parts by weight of radices paeoniae alba, 10 to 20 parts by weight of white atractylodes rhizome, 20 to 30 parts by weight of apricot kernel, 20 to 30 parts by weight of angelica, 20 to 30 parts by weight of coix seed, By weight of a French chalk, 5 to 10 parts by weight of zinc oxide, and 5 to 10 parts by weight of bolus alba.

The advantageous effect of the present invention is that the raw materials of traditional Chinese medicines can interact with each other, act as a synergistic effect, promote blood circulation in the face, and absorb waste and toxic gases.

Traditional Chinese medicinal facial masks promote the penetration of nutritive and effective substances into the deep layers of the skin and provide additional benefits such as moisture retention, skin moisturization, whitening, freckle removal, anti wrinkle, anti-aging, anti- It plays a role.

In addition, the various components of the facial mask provided by the present invention may have interactions leading to a lengthy quality assurance period.

Finally, the facial mask provided by the present invention includes only natural plants and does not contain any chemical components. Thus, the present invention makes the skin of people healthy and thus has no hurt.

The following examples further disclose and demonstrate embodiments within the scope of the present invention. It is to be understood that the embodiments have been given for purposes of illustration only and are not intended to limit the invention, many variations thereof being possible without departing from the spirit and scope of the invention.

According to an aspect of the present invention, there is provided a ginseng powder comprising 10 to 20 parts by weight of ginseng, 10 to 20 parts by weight of pearl powder, 10 to 20 parts by weight of grit, 10 to 20 parts by weight of vinegar, 10 to 20 parts by weight, 20 to 30 parts by weight of white paper, 20 to 30 parts by weight of phosphorus, 10 to 15 parts by weight of French chalk, 5 to 10 parts by weight of zinc oxide and 5 to 10 parts by weight of Bolus alba.

According to a first embodiment of the present invention, the facial mask composition comprises 10 parts by weight of ginseng, 10 parts by weight of pearl powder, 10 parts by weight of peanuts, 10 parts by weight of peel, 10 parts by weight of lead, 20 parts by weight of lead, 20 parts by weight of white paper, 20 parts by weight of phosphorus, 10 parts by weight of French choke, 5 parts by weight of zinc oxide and 5 parts by weight of Bolus alba.

According to a second embodiment of the present invention, the face mask composition comprises 20 parts by weight of ginseng, 20 parts by weight of pearl powder, 20 parts by weight of peanuts, 20 parts by weight of vinegar, 20 parts by weight of lead, 30 parts by weight of lead, 30 parts by weight of phosphorus, 15 parts by weight of French choke, 10 parts by weight of zinc oxide and 10 parts by weight of Bolus alba.

According to a third embodiment of the present invention, the face mask composition comprises 10 parts by weight of ginseng, 20 parts by weight of pearl powder, 10 parts by weight of corn, 20 parts by weight of vinegar, 10 parts by weight of carnauba wax, 30 parts by weight of passerine, 20 parts by weight of white paper, 30 parts by weight of phosphorus, 10 parts by weight of French choke, 10 parts by weight of zinc oxide and 5 parts by weight of bolus alba.

According to a fourth embodiment of the present invention, the facial mask composition comprises 20 parts by weight of ginseng, 10 parts by weight of pearl powder, 20 parts by weight of peel, 10 parts by weight of peony, 20 parts by weight of extract, 20 parts by weight of passerine, 20 parts by weight of phosphorus, 15 parts by weight of French chalk, 5 parts by weight of zinc oxide and 10 parts by weight of Bolus alba.

According to a fifth embodiment of the present invention, the facial mask composition comprises 15 parts by weight of ginseng, 15 parts by weight of pearl powder, 15 parts by weight of peat, 15 parts by weight of peat, 15 parts by weight of lead, 25 parts by weight of lead, 25 parts by weight of phosphorus, 12.5 parts by weight of French chalk, 7.5 parts by weight of zinc oxide and 7.5 parts by weight of Bolus alba.

According to a sixth embodiment of the present invention, a facial mask composition comprises 10 parts by weight of ginseng, 15 parts by weight of pearl powder, 10 parts by weight of peanuts, 15 parts by weight of vinegar, 10 parts by weight of boron, 5 parts by weight of passerine, 20 parts by weight of white paper, 25 parts by weight of phosphorus, 10 parts by weight of French chalk, 7.5 parts by weight of zinc oxide, and 5 parts by weight of Bolus alba.

According to a seventh embodiment of the present invention, the face mask composition comprises 20 parts by weight of ginseng, 15 parts by weight of pearl powder, 20 parts by weight of peanuts, 15 parts by weight of vinegar, 20 parts by weight of lead, 25 parts by weight of lead, 25 parts by weight of phosphorus, 15 parts by weight of French chalk, 7.5 parts by weight of zinc oxide and 10 parts by weight of Bolus alba.

According to an eighth embodiment of the present invention, the facial mask composition comprises 15 parts by weight of ginseng, 10 parts by weight of pearl powder, 15 parts by weight of pebbles, 10 parts by weight of vinegar, 15 parts by weight of lead, 20 parts by weight of lead, 20 parts by weight of phosphorus, 7.5 parts by weight of French chalk, 5 parts by weight of zinc oxide and 7.5 parts by weight of Bolus alba.

According to a ninth embodiment of the present invention, the face mask composition comprises 15 parts by weight of ginseng, 20 parts by weight of pearl powder, 15 parts by weight of peanuts, 20 parts by weight of vinegar, 15 parts by weight of lead, 30 parts by weight of lead, 30 parts by weight of phosphorus, 12.5 parts by weight of French chalk, 10 parts by weight of zinc oxide and 7.5 parts by weight of Bolus alba.

According to a tenth embodiment of the present invention, the face mask composition comprises 12 parts by weight of ginseng, 18 parts by weight of pearl powder, 14 parts by weight of pebbles, 16 parts by weight of vinegar, 13 parts by weight of lead, 27 parts by weight of lead, 26 parts by weight of phosphorus, 12 parts by weight of French chalk, 7 parts by weight of zinc oxide and 8 parts by weight of Bolus alba.

According to an eleventh embodiment of the present invention, the face mask composition comprises 11 parts by weight of ginseng, 19 parts by weight of pearl powder, 13 parts by weight of pebbles, 17 parts by weight of vinegar, 15 parts by weight of lead, 27 parts by weight of lead, 21 parts by weight of phosphorus, 13 parts by weight of French chalk, 6 parts by weight of zinc oxide and 8 parts by weight of Bolus alba.

According to a twelfth embodiment of the present invention, the facial mask composition comprises 18 parts by weight of ginseng, 12 parts by weight of pearl powder, 16 parts by weight of peel, 14 parts by weight of peel, 11 parts by weight of boric acid, 21 parts by weight of passerine, 21 parts by weight of phosphorus, 16 parts by weight of French choke, 8 parts by weight of zinc oxide and 7 parts by weight of Bolus alba.

According to a thirteenth embodiment of the present invention, the face mask composition comprises 17 parts by weight of ginseng, 18 parts by weight of pearl powder, 19 parts by weight of peanuts, 16 parts by weight of vinegar, 15 parts by weight of alumina, 24 parts by weight of alumina, 22 parts by weight of phosphorus, 11 parts by weight of French choke, 6 parts by weight of zinc oxide and 7 parts by weight of Bolus alba.

It is worthy to note that the term " weight "means the ratio between each element or component, but does not imply a ratio over the total weight.

Manufacturing method

The materials or components described above are commercially available in the market or can be obtained, for example, by conventional drying methods, which can be obtained by drying these materials and pulverizing the material to a powder having an average particle size range of 20 to 30 mesh Lt; / RTI >

The manufacture of traditional Chinese medicinal extracts includes the following operations.

Supercritical carbon dioxide extraction was carried out using ethanol as a solvent at 30 MPa and 60 DEG C for 0.5 hour to obtain powders by mixing and pulverizing the respective materials so as to be powders. In particular, the amount of ethanol is 2 ml per gram of the powder, the analytical pressure is 10 MPa and the analysis temperature is 20 ° C.

The reduced pressure concentration and ethanol recovery were carried out to obtain an ethanol extract concentrate.

Boiling the residue twice after performing supercritical carbon dioxide extraction, wherein the first boiling step boils in 8 to 10 times water of the residue for 30 to 50 minutes; The second boiling step boils in 9 to 12 times water of the residue for 80 to 90 minutes.

The boiled liquid was filtered and the filtered liquid was combined, which was then concentrated to a liquid having a density of 1.3 to 1.5 at 50 ° C.

 A liquid having a density of 1.3 to 1.5 was dried to obtain an extract.

The extract was diluted with a certain amount of water and mixed with the same volume of D-101 macroporous adsorbent resin, using D-101 or AB-8 type, Other nonpolar, weakly polar or intermediate polar macroporous adsorbent resin. The loaded volume was calculated at a ratio of 1: 3 between product volume to resin. After 15 minutes of static adsorption, elution was carried out using 10 times the volume of ethanol with different densities, and 60% -70% ethanol elution solution was collected to obtain a brown powder.

In addition, the powder was mixed with a mucus-like brown oil similar to that obtained through supercritical carbon dioxide extraction, thereby obtaining a transitional Chinese medicinal extract.

Using a UVB-induced pigmentation model, traditional Chinese medicines were administered as follows.

Three separate areas (2 cm x 2 cm) were selected on the back of each guinea pig, and the long hair of each guinea pig was cut with scissors and the short hair was removed using an electric razor. The regions were then examined using a light therapy device of the SS-04B type with a UVB light source having a spectral peak of 310 to 315 nm. The regions were the amount of 200mJ / cm 2 for 20 minutes daily irradiation was continued for two weeks, the irradiation (irradiation), 2800mJ / cm 2 of A cumulative dose was obtained. The drug was administered 2 hours after the completion of the study and the drug administration continued for 2 weeks after the completion of the study. The facial tissue was then taken for pathological examination.

Samples were divided into three groups to observe the number of cells containing melanin and DOPA positive cells.

Group 1: reference group containing the back skin of normal guinea pigs not irradiated by UVB;

Group 2: a group comprising the back skin of guinea pigs, which was examined by UVB but was not applied with the traditional Chinese medicines of the present invention;

Group 3: a group comprising the back skin of guinea pigs applied with the traditional Chinese medicines of Embodiments 1 to 13 after UVB irradiation, wherein the concentrations are 0.5 and 1 mg / ml, respectively.

Dyeing process

1) HE staining: Skin samples (2 cm x 2 cm) such as guinea pigs were HE-stained using conventional paraffin sections.

2) Schmor staining:

a. The sections were rinsed with water;

b. The slice was then treated with a mixture of 40 ml of FeCl 3 solution having a concentration of 0.04 mol / L, 6 ml of potassium ferricyanide solution having a concentration of 0.04 mol / L and 6 ml of distilled water for 10 minutes;

c. Thereafter, the slice was rinsed with running water.

Results: Melanocytes were stained with brown and black particles.

3) Imokawa dyeing

a. A skin sample (2 cm x 2 cm) was taken from a guinea pig or the like and rinsed with PBS liquid having a concentration of 0.1 mol / L (PH 6.8) and then incubated for 5 hours at 37 캜 with sodium bromide .

b. The cuticle and dermis of the skin were separated.

c. The cuticle was conditioned for 30 minutes using a cold neutral formalin solution with a concentration of 3.33 mol / L (10%) and then washed twice with a PBS solution having a concentration of 0.1 mol / L (PH6.8) Respectively.

d. The cuticle was then stained with PBS solution having a concentration of 0.1 mol / L for 5 hours.

Results: Melanocytes were stained with black and brown particles.

Optical microscope observation

1) Calculation of Melanin Particle Cells: The Schmorl staining progresses in mm 2 of the cuticle substrate of each sample The number of melanin particles in the sac was calculated using a Net eyed micrometer single blind method under high magnification lens;

2) Calculation of DOPA-positive cells: Imokawa staining progresses in the mm 2 of the cuticle substrate of each sample The number of peritoneal DOPA positive melanocytes was calculated using a true eyelid micrometer single blind method under high magnification lens.

group Calculation of melanin particle cells Calculation of DOPA positive melanocytes Unexamined group 356.57 161.40 Investigated groups 489.51 256.63 Embodiment 1 373.00 173.34 Embodiment 2 385.24 185.87 Embodiment 3 384.71 186.68 Embodiment 4 385.00 187.61 Embodiment 5 369.96 170.80 Embodiment 6 385.00 185.35 Embodiment 7 383.49 184.10 Embodiment 8 386.02 183.05 Embodiment 9 384.97 186.89 Embodiment 10 385.49 185.01 Embodiment 11 375.17 175.56 Embodiment 12 377.19 180.37 Embodiment 13 384.21 187.56

Table 1 shows the average number of melanin particle cells and DOPA positive melanocyte cells for unirradiated group, irradiated group, and group applied with a facial mask according to Embodiments 1 to 13 of the present invention.

Compared to the reference group, the second group exposed under UVB irradiation had a higher number of melanin particle cells and DOPA positive melanocyte cells.

After application of Embodiments 1-13 of the present invention, the number of melanin particles and cuticle DOPA positive melanocytes was significantly reduced to a level very close to the reference group. Obviously, the present invention exhibits excellent effects in skin whitening and chloasma removal.

In particular, Embodiment 5 exhibits the best effects in Embodiments 1 to 13 in reducing the number of melanin particle cells and DOPA positive melanocyte cells, and sometimes this embodiment reaches a level very close to the reference group.

Furthermore, Embodiments 1, 11, and 12 also show relatively superior performance compared to the other embodiments except for Embodiment 1.

The facial mask of the present invention is suitable for topical application to the skin of the body, particularly the skin of the face. The use of the present invention provides a skin conditioning effect, such as smoothness, softness, and moisturisation, to the skin due to the deposition and penetration of various components.

The advantages of the present invention are provided by the application of the present mask composition in terms of a specific effect such as a chronic whitening agent and skin benefit agents contained in the emulsified liquid composition. The mask composition of the present invention is particularly advantageous for delivering nutrients and other effects into the skin.

The use of a mask composition of the present invention having an insoluble substrate as a transfer medium over a long period of time, as compared to when a liquid composition is applied to the skin without the use of an insoluble substrate, results in excellent distribution and deposition of such agents, Lt; RTI ID = 0.0 > of these agents. ≪ / RTI >

In addition, when an insoluble substrate having low air permeability is used, a more effective penetration of the skin effect agent into the skin is expected. The mask composition of the present invention is also believed to provide a mental benefit to the user upon use, such as a refreshing feel and a relaxation feel.

In one preferred embodiment, the mask composition is used to treat facial skin by the following steps: (a) applying the mask composition to most areas of the facial skin; (b) placing the mask composition on the facial skin for a period of time that is not longer than any portion of the mask composition being dried; (c) removing the mask composition from the facial skin; And (d) removing the remaining liquid composition remaining on the facial skin.

The mask composition is immersed in an aqueous liquid composition so that the mask fits on the facial skin by gently placing it on the skin. For better fit and uniform distribution of nutrients and other skin benefit agents, the mask was pressed against the facial skin using a fingertip.

Claims (5)

10-20 parts by weight of ginseng, 10-20 parts by weight of pearl powder, 10-20 parts by weight of Angelica dahurica, 10-20 parts by weight of radices paeoniae alba, 10-20 parts by weight of 20 to 30 parts by weight of angelica, 20 to 30 parts by weight of coix seed, 10 to 15 parts by weight of French chalk, 5 to 10 parts by weight of zinc oxide, and 5 to 10 parts by weight of bolus alba. A pharmaceutical composition according to claim 1, which comprises 10 parts by weight of ginseng, 10 parts by weight of pearl powder, 10 parts by weight of corn, 10 parts by weight of vinegar, 10 parts by weight of carnauba wax, 20 parts by weight of passerine, 20 parts by weight of white paper, 20 parts by weight of phosphorus, Chalk, 5 parts by weight of zinc oxide, and 5 parts by weight of bolus alba. A pharmaceutical composition according to claim 1, which comprises 15 parts by weight of ginseng, 15 parts by weight of pearl powder, 15 parts by weight of peel, 15 parts by weight of vinegar, 15 parts by weight of bauxite, 25 parts by weight of lead, 25 parts by weight of white paper, 25 parts by weight of phosphorus, Chalk, 7.5 parts by weight of zinc oxide, and 7.5 parts by weight of Bolus alba. The pharmaceutical composition according to claim 1, which comprises 11 parts by weight of ginseng, 19 parts by weight of pearl powder, 13 parts by weight of peel, 17 parts by weight of vinegar, 15 parts by weight of lead, 27 parts by weight of lead, 23 parts by weight of white paper, 21 parts by weight of phosphorus, Chalk, 6 parts by weight of zinc oxide, and 8 parts by weight of Bolus alba. The pharmaceutical composition according to claim 1, which comprises 18 parts by weight of ginseng, 12 parts by weight of pearl powder, 16 parts by weight of peel, 14 parts by weight of vinegar, 11 parts by weight of alumina, 21 parts by weight of alumina, 23 parts by weight of white paper, 21 parts by weight of phosphorus, Chalk, 8 parts by weight of zinc oxide, and 7 parts by weight of Bolus alba.
KR1020160146680A 2016-11-04 2016-11-04 Facial mask KR20180050028A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020160146680A KR20180050028A (en) 2016-11-04 2016-11-04 Facial mask

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160146680A KR20180050028A (en) 2016-11-04 2016-11-04 Facial mask

Publications (1)

Publication Number Publication Date
KR20180050028A true KR20180050028A (en) 2018-05-14

Family

ID=62188195

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160146680A KR20180050028A (en) 2016-11-04 2016-11-04 Facial mask

Country Status (1)

Country Link
KR (1) KR20180050028A (en)

Similar Documents

Publication Publication Date Title
CN108524414A (en) A kind of more effect Chinese pitted skin films and its preparation process
CN110664643A (en) Polypeptide essence with multiple-effect whitening effect and preparation method thereof
KR20180000553A (en) Cosmetics composition
KR20180029578A (en) Facial mask
CN104784297A (en) Skin allergy prevention composition
CN106619278A (en) Traditional Chinese medicine combination extract with effects of removing beverage and whitening skin and application
KR20180050028A (en) Facial mask
KR20180044538A (en) Facial mask
KR20180065111A (en) Facial mask
KR20180033673A (en) Facial mask
KR20180000513A (en) Cosmetics Composition
KR20170136954A (en) Facial mask compositions
KR20180029579A (en) Facial mask
CN103479615B (en) The application of epigallocatechin gallate (EGCG) cetylate and one treat psoriatic pharmaceutical composition
KR20180052286A (en) Facial mask
KR20180063599A (en) Facial mask
KR20180022430A (en) Facial mask
KR20180035371A (en) Facial mask
KR20180036186A (en) Facial mask
KR20170136959A (en) Facial mask compositions
KR20180016788A (en) Facial mask
KR20180036136A (en) Facial mask
KR20180031171A (en) Facial mask
CN103463308B (en) The application of tea polyphenols stearate and one treat psoriatic pharmaceutical composition
KR20180033859A (en) Facial mask